Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Organic & Biomolecular Chemistry
|
June 10, 2006
Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation
Huchen Zhou, De-an Wang, Laura Baldini, et al.
Bioorganic & Medicinal Chemistry
|
November 22, 2020
Discovery of benzhydrol-oxaborole derivatives as Streptococcus pneumoniae leucyl-tRNA synthetase inhibitors
Guiyun Hao, Hao Li, Fei Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 21, 2011
Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors
Zhitao Qiao, Weiwei Wang, Lie Wang, et al.
Organic & Biomolecular Chemistry
|
July 12, 2013
Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors
Fenglong Zhang, Jin Du, Qing Wang, et al.
Applied and Environmental Microbiology
|
October 7, 2008
Selective removal of aberrant extender units by a type II thioesterase for efficient FR-008/candicidin biosynthesis in Streptomyces sp. strain FR-008
Yongjun Zhou, Qingqing Meng, Delin You, et al.
Oncotargets and Therapy
|
October 29, 2015
A human leucyl-tRNA synthetase as an anticancer target
Guangwei Gao, Ying Yao, Kun Li, et al.
Journal of Medicinal Chemistry
|
February 25, 2012
Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents
Zhitao Qiao, Qi Wang, Fenglong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 24, 2009
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Tsutomu Akama, Stephen J Baker, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis
Stephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.
Acta Pharmaceutica Sinica. B
|
January 14, 2025
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
Lu Liu, Yuanlai Qiu, Yuying Suo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Organic & Biomolecular Chemistry
|
June 10, 2006
Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation
Huchen Zhou, De-an Wang, Laura Baldini, et al.
Bioorganic & Medicinal Chemistry
|
November 22, 2020
Discovery of benzhydrol-oxaborole derivatives as Streptococcus pneumoniae leucyl-tRNA synthetase inhibitors
Guiyun Hao, Hao Li, Fei Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 21, 2011
Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors
Zhitao Qiao, Weiwei Wang, Lie Wang, et al.
Organic & Biomolecular Chemistry
|
July 12, 2013
Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors
Fenglong Zhang, Jin Du, Qing Wang, et al.
Applied and Environmental Microbiology
|
October 7, 2008
Selective removal of aberrant extender units by a type II thioesterase for efficient FR-008/candicidin biosynthesis in Streptomyces sp. strain FR-008
Yongjun Zhou, Qingqing Meng, Delin You, et al.
Oncotargets and Therapy
|
October 29, 2015
A human leucyl-tRNA synthetase as an anticancer target
Guangwei Gao, Ying Yao, Kun Li, et al.
Journal of Medicinal Chemistry
|
February 25, 2012
Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents
Zhitao Qiao, Qi Wang, Fenglong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 24, 2009
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Tsutomu Akama, Stephen J Baker, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis
Stephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.
Acta Pharmaceutica Sinica. B
|
January 14, 2025
Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
Lu Liu, Yuanlai Qiu, Yuying Suo, et al.
Page
of 5